In studies in adults with obesity or overweight with risk factors like high blood pressure or high cholesterol, the percentage of patients losing at least 10% of their body weight were 37% (taking the 7.5 mg/46 mg dose) and 48% (taking 15 mg/92 mg dose), compared to 7% of those taking a placebo
Personalization through genetic context can help providers and patients select the approach most likely to succeed
A microinfusion serum that suits a 38-year-old with early fine lines is not the same protocol as one that suits a 46-year-old with melasma
Without adequate levels of carnitine, our fats will be unable to enter mitochondria, which suggests depleted energy stores
Molecular pathways: Cbl proteins in tumorigenesis and antitumor immunityopportunities for cancer treatment
By combining convenient neighborhood locations, virtual care access and clinically guided treatment plans, MinuteClinic is helping expand access to evidence-based weight management care in communities across the country.